{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/influenza-seasonal/have-i-got-the-right-topic/","result":{"pageContext":{"chapter":{"id":"39d27467-6801-59da-a28b-29a9a1aa848d","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","depth":1,"htmlHeader":"<!-- begin field e108784e-0df1-4605-a66f-a8d558722b8e --><h1>Have I got the right topic?</h1><!-- end field e108784e-0df1-4605-a66f-a8d558722b8e -->","summary":null,"htmlStringContent":"<!-- begin item 1bff20db-f57a-4903-85ac-1e686192bbb7 --><!-- begin field 42945ffc-0023-4f50-9b3c-acbc015a6e06 --><p>From birth onwards.</p><!-- end field 42945ffc-0023-4f50-9b3c-acbc015a6e06 --><!-- begin field d60f3643-9bd9-4a10-a11f-65ddfe97486f --><p>This CKS topic is largely based on the Public Health England (PHE) guidance <em>PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/influenza-seasonal/references/\">PHE, 2019</a>], the National Institute for Health and Care Excellence (NICE) technology appraisals <em>Amantadine, oseltamivir and zanamivir for the treatment of influenza </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/influenza-seasonal/references/\">NICE, 2014a</a>] and <em>Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/influenza-seasonal/references/\">NICE, 2014b</a>], the British Medical Journal (BMJ) best practice guide <em>Influenza infection</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/influenza-seasonal/references/\">BMJ, 2019</a>], and expert opinion in a narrative review <em>Influenza</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/influenza-seasonal/references/\">Paules, 2017</a>].</p><p>This CKS topic covers the management of seasonal influenza and post-exposure prophylaxis of seasonal influenza. However, prophylaxis of seasonal influenza is <em>not </em>a replacement for immunization; there is a separate CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-seasonal-influenza/\">Immunizations - seasonal influenza</a>.</p><p>This CKS topic does not cover avian or swine influenza, or the management of pandemics. It does not cover influenza immunization, or the management of complications of influenza, such as chest infections, pneumonia, and otitis media.</p><p>There are separate CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/chest-infections-adult/\">Chest infections - adult</a>, <a class=\"topic-reference external-reference\" href=\"/topics/common-cold/\">Common cold</a>, <a class=\"topic-reference external-reference\" href=\"/topics/cough-acute-with-chest-signs-in-children/\">Cough - acute with chest signs in children</a>, <a class=\"topic-reference external-reference\" href=\"/topics/otitis-media-acute/\">Otitis media - acute</a>, <a class=\"topic-reference external-reference\" href=\"/topics/sinusitis/\">Sinusitis</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/sore-throat-acute/\">Sore throat - acute</a>.</p><p>The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.</p><!-- end field d60f3643-9bd9-4a10-a11f-65ddfe97486f --><!-- end item 1bff20db-f57a-4903-85ac-1e686192bbb7 -->","topic":{"id":"7143131b-dc98-5d14-aef2-f50114a27d13","topicId":"c00149e5-18ab-49c6-8576-089384091df2","topicName":"Influenza - seasonal","slug":"influenza-seasonal","lastRevised":"Last revised in August 2020","chapters":[{"id":"415ca83c-583b-5dd7-8ce7-a67a72325836","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"39d27467-6801-59da-a28b-29a9a1aa848d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7326279e-c8e9-5783-9cb0-433a2e0c5061","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ecde5124-7df2-5d70-921e-cfa13a752476","slug":"changes","fullItemName":"Changes"},{"id":"b4d67dc6-a391-5644-a3a4-89c1c0c49e3f","slug":"update","fullItemName":"Update"}]},{"id":"3b2a94ae-a366-5ff9-8a35-6f8eb63736a1","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8b66965c-fc03-5267-ac06-f0edc2bf81ea","slug":"goals","fullItemName":"Goals"},{"id":"32bc1d45-c0ea-55ed-8723-fdbf13b7196e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c5aa9558-010a-5b32-b95a-40f647ef373e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b9c5c598-f72e-505f-b951-cbe710a6af02","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d0c6ad8d-5845-5dfd-b2d0-b04bb5395c62","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"48e0bfcd-fd33-552c-b052-28533a176218","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"feb6e56c-e4f6-57f4-bbee-0876089197e0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"bc17d7e2-a53a-595c-9f57-7080c9814001","slug":"definition","fullItemName":"Definition"},{"id":"d0475ee5-11e2-5ad5-8628-4f513e50236f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a0aabed4-a912-518e-9257-8653bc7541e4","slug":"complications","fullItemName":"Complications"}]},{"id":"f81fdd28-028a-5558-92b2-90a1569692bb","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dcd79bc4-67e6-52b5-af13-ab18772e4c55","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"4da6c7b5-c872-551a-aff9-100bef3041ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b540d9e5-48f5-5b1c-a8b1-8a37d951449f","fullItemName":"Management","slug":"management","subChapters":[{"id":"9cbc6ee5-b0da-5b46-9ce4-3704f7cf24a9","slug":"treating-influenza","fullItemName":"Scenario: Treating influenza"},{"id":"b82606d4-79c4-5b96-84cd-115c371c80b4","slug":"post-exposure-prophylaxis","fullItemName":"Scenario: Post-exposure prophylaxis"}]},{"id":"267c67be-5fb6-510f-b3f7-15ece61003d9","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"418c695e-c703-5e30-9ec2-9bf2afeb6001","slug":"oseltamivir","fullItemName":"Oseltamivir"},{"id":"370b7394-2bad-5d4f-ac2a-06de67bbefea","slug":"zanamivir","fullItemName":"Zanamivir"}]},{"id":"83f51ef5-d6f9-5101-849d-c72bd5975126","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"fe85159c-da36-5171-9b52-88d8edd9ee77","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"46f280be-d769-501b-905f-789bbf2d8454","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9904923d-c7de-53aa-8253-15c9392ece2e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"3790de44-d79a-5486-b053-d09c6dccc2cc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7e631b66-3030-5dd0-97e7-7504198b5a14","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ab624014-37fa-5613-976c-e2ffa65a7e90","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"85b4d3fc-b6de-5df4-ad98-bf9ea439e342","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}